Showing results (101-110 of 134) with videos related to
Sort By:
Pageof 14
The Ulster Medical Journal|July 26, 2002
Successful colonoscopy; completion rates and reasons for incompletionR M S Mitchell, K McCallion, K R Gardiner, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1989
Reactivity of a human monoclonal antibody against carcinomas and other lesions of the colonS C Formenti, M S Mitchell, C R Taylor, et al.Surgery|September 1, 1982
Intralymphatic and regional surgical adjuvant immunotherapy in high-risk melanoma of the extremitiesS Ariyan, J M Kirkwood, M S Mitchell, et al.Cancer Research|September 1, 1984
Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracilC P Spears, B G Gustavsson, M S Mitchell, et al.Cancer Investigation|January 1, 1984
Kaposi's sarcoma and autoimmune thrombocytopeniaR L Modlin, R A Kempf, M S Mitchell, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1988
Effectiveness and tolerability of low-dose cyclophosphamide and low-dose intravenous interleukin-2 in disseminated melanoma [corrected]M S Mitchell, R A Kempf, W Harel, et al.Annals of the Rheumatic Diseases|April 1, 1990
Genes associated with rheumatoid arthritis and mild inflammatory arthritis. I. Major histocompatibility complex class I, II, and III allotypesA H Puttick, D C Briggs, K I Welsh, et al.Cancer Research|October 1, 1990
Increased lysis of melanoma by in vivo-elicited human lymphokine-activated killer cells after addition of antiganglioside antibodies in vitroW Harel, H Shau, C G Hadley, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Active specific immunotherapy of metastatic melanoma with an antiidiotype vaccine: a phase I/II trial of I-Mel-2 plus SAF-mW D Quan, G E Dean, L Spears, et al.International Journal of Cancer|June 17, 1998
Anti-MUC1 class I restricted CTLs in metastatic breast cancer patients immunized with a synthetic MUC1 peptideM Reddish, G D MacLean, R R Koganty, et al.Pageof 14